Furthermore, pathway enrichment analysis showed that GTF2IRD1 may be involved in pancreatic adenocarcinoma pathway, TGF-β signaling pathway, T-cell receptor signaling pathway, leukocyte transendothelial migration, resistin as a regulator of inflammation (Table 3). This evidence concerns the gene TGFB1 and pancreatic adenocarcinoma.